The Contribution of Harold F. Dvorak to the Study of Tumor Angiogenesis and Stroma Generation Mechanisms

REFERENCES

• Benjamin L. E., Golijanin D., Itin A., Pode D., Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. Journal of Clinical Investigation 1999; 103: 159–165
   PubMed Web of Science ®Google Scholar
• Benjamin L. E., Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 8761–8776
   PubMed Web of Science ®Google Scholar
• Brown L. F., Lanir N., McDonagh J., Tognazzi K., Dvorak A. M., Dvorak H. F. Fibroblast migration in fibrin gel matrices. American Journal of Pathology 1993; 142: 273–283
   PubMed Web of Science ®Google Scholar
• Brown L. F., Van De Water L., Harvey V. S., Dvorak H. F. Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma. American Journal of Pathology 1988; 130: 455–465
   PubMed Web of Science ®Google Scholar
• Brown L. F., Yeo K. T., Berse B., Yeo T. K., Senger D. R., Dvorak H. F., Van De Water L. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. Journal of Experimental Medicine 1992; 176: 1375–1379
   PubMed Web of Science ®Google Scholar
• Collins P. D., Connolly D. T., Williams T. J. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. British Journal of Pharmacology 1993; 109: 195–199
   PubMed Web of Science ®Google Scholar
• Connolly D. T., Heuvelman D. M., Nelson R., Olander J. V., Eppley B. L., Delfino J. J., Siegel N. R., Leimgruber R. M., Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. Journal of Clinical Investigation 1989; 84: 1470–1478
   PubMed Web of Science ®Google Scholar
• Dvorak A. M., Kohn S., Morgan E. S., Fox P., Nagy J. A., Dvorak H. F. The vesiculo-vacuolar organelle (VVO): A distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. Journal of Leukocyte Biology 1996; 59: 100–115
   PubMed Web of Science ®Google Scholar
• Dvorak H. F. Tumors: Wounds that not heal. Similarities between tumor stroma generation and wound healing. New England Journal of Medicine 1986; 315: 1650–1659
   PubMed Web of Science ®Google Scholar
• Dvorak H. F., Dickersin G. R., Dvorak A. M., Manseau E. J., Pyne K. Human breast carcinoma: Fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction. Journal of the National Cancer Institute 1981; 67: 337–345
   Google Scholar
• Dvorak H. F., Dvorak A. M., Churchill W. H. Immunologic rejection of diethylnitrosamine-induced hepatomas in strain 2 guinea pigs: Participation of basophilic leukocytes and macrophage aggregates. Journal of Experimental Medicine 1973; 137: 751–755
   PubMed Web of Science ®Google Scholar
• Dvorak H. F., Dvorak A. M., Manseau E. J., Wiberg L., Churchill W. H. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. Journal of the National Cancer Institute 1979a; 62: 1459–1472
   PubMed Web of Science ®Google Scholar
• Dvorak H. F., Dvorak A. M., Simpson B. A., Richerson H. B., Leskowitz S., Karnovsky M. J. Cutaneous basophil hypersensitivity. II. A light and electron microscopic description. Journal of Experimental Medicine 1970; 132: 558–582
   PubMed Web of Science ®Google Scholar
• Dvorak H. F., Harvey V. S., Estrella P., Brown L. F., McDonagh J. Fibrin-containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Laboratory Investigation 1987; 57: 673–686
   PubMed Web of Science ®Google Scholar
• Dvorak H. F., Harvey V. S., McDonagh J. Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas. Cancer Research 1984; 44: 3348–3354
   PubMed Web of Science ®Google Scholar
• Dvorak H. F., Nagy J. A., Berse B., Brown L. F., Yeo K. T., Yeo T. K., Dvorak A. M., van de Water L., Sioussat T. M., Senger D. R. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Annals of the New York Academy of Sciences 1992; 667: 101–111
   PubMed Web of Science ®Google Scholar
• Dvorak H. F., Orenstein N. S., Carvalho A. C., Churchill W. H., Dvorak A. M., Galli S. J., Feder A. M., Rypysc J., Giovinco F. Induction of a fibrin-gel investment: An early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. Journal of Immunology 1979b; 122: 166–174
   PubMed Web of Science ®Google Scholar
• Dvorak H. F., Senger D. R., Dvorak A. M. Fibrin as a component of the tumor stroma: Origins and biological significance. Cancer Metastasis Reviews 1983; 2: 41–73
   PubMed Web of Science ®Google Scholar
• Feng D., Nagy J., Hipp J., Dvorak H., Dvorak A. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine and serotonic. Journal of Experimental Medicine 1996; 183: 1981–1986
   PubMed Web of Science ®Google Scholar
• Feng D., Nagy J. A., Dvorak H. F., Dvorak A. M. Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor-associated microvessels in man and animals. Microscopy Research Technique 2002; 57: 289–326
   PubMed Web of Science ®Google Scholar
• Ferrara N., Henzel W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochemical Biophysical Research Communications 1989; 161: 851–858
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D., Abraham J. A., Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proceedings of the National Academy of Sciences of the United States of America 1989; 86: 7311–7315
   PubMed Web of Science ®Google Scholar
• Harris N. L., Dvorak A. M., Smith J., Dvorak H. F. Fibrin deposits in Hodgkin's disease. American Journal of Pathology 1982; 108: 119–129
   PubMed Web of Science ®Google Scholar
• Lantos P., Vandenberg S., Kleihues P. Tumors of the nervous system. Greenfield's Neuropathology, 6th ed., D. Graham, D. Lantos. Arnold, London 1997; 583–897
   Google Scholar
• Leung D. W., Cachianes G., Kuang W. J., Goeddel D. V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306–1309
   PubMed Web of Science ®Google Scholar
• McKee P. Pathology of the Skin With Clinical Correlations. Mosby International, London 1996; 16.57–16.66
   Google Scholar
• Miles A. A., Miles E. M. Vascular reaction to histamine, histamine-liberator, and leukotaxine in the skin of guinea pigs. Journal of Physiology 1952; 118: 228–257
   PubMed Web of Science ®Google Scholar
• Nagy J. A., Masse E. M., Herzberg K. T., Meyers M. S., Yeo K. T., Sioussat T. M., Dvorak H. F. Pathogenesis of ascites tumor growth. Vascular permeability factor, vascular hyperpermeability and ascites fluid accumulation. Cancer Research 1995; 55: 360–368
   PubMed Web of Science ®Google Scholar
• Peters K., De Vries C., Williams L. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proceedings of the National Academy of Sciences of the United States of America 1993; 90: 8915–8919
   PubMed Web of Science ®Google Scholar
• Pettersson A., Nagy J. A., Brown L. F., Sundberg C., Morgan E., Jungles S., Carter R., Krieger J. E., Manseau E. J., Harvey V. S., Eckelhoefer I. A., Feng D., Dvorak A. M., Mulligan R. C., Dvorak H. F. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Laboratory Investigation 2000; 80: 99–115
   PubMed Web of Science ®Google Scholar
• Senger D. R., Galli S. J., Dvorak A. M., Perruzzi C. A., Harvey V. S., Dvorak H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983–985
   PubMed Web of Science ®Google Scholar
• Senger D. R., van de Water L., Brown L. F., Nagy J. A., Yeo K. T., Berse B., Jackman R. W., Dvorak A. M., Dvorak H. F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Reviews 1993; 12: 303–324
   PubMed Web of Science ®Google Scholar
• Watanabe Y., Lee S. W., Detmar M., Ajioka I., Dvorak H. F. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene 1997; 14: 2025–2032
   PubMed Web of Science ®Google Scholar
• Yeo T. K., Senger D. R., Dvorak H. F., Freter L., Yeo K. T. Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Biochemical Biophysical Research Communications 1991; 179: 1568–1575
   PubMed Web of Science ®Google Scholar